Literature DB >> 18558101

Sphingosine-1-phosphate lyase in development and disease: sphingolipid metabolism takes flight.

Henrik Fyrst1, Julie D Saba.   

Abstract

Sphingosine-1-phosphate lyase (SPL) is a highly conserved enzyme that catalyses the final step of sphingolipid degradation, namely the irreversible cleavage of the carbon chain at positions 2-3 of a long-chain base phosphate (LCBP), thereby yielding a long-chain aldehyde and phosphoethanolamine. LCBPs are potent signaling molecules involved in cell proliferation, survival, migration, cell-cell interactions and cell stress responses. Therefore, tight regulation of LCBP signaling is required for proper cell function, and perturbations of this system can lead to alterations in biological processes including development, reproduction and physiology. SPL is a key enzyme in regulating the intracellular and circulating levels of LCBPs and is, therefore, gaining attention as a putative target for pharmacological intervention. This review provides an overview of our current understanding of SPL structure and function, mechanisms involved in SPL regulation and the role of SPL in development and disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558101      PMCID: PMC2749932          DOI: 10.1016/j.bbalip.2008.05.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  107 in total

Review 1.  Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors.

Authors:  S Pyne; N Pyne
Journal:  Pharmacol Ther       Date:  2000-11       Impact factor: 12.310

2.  Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death.

Authors:  S M Mandala; R Thornton; I Galve-Roperh; S Poulton; C Peterson; A Olivera; J Bergstrom; M B Kurtz; S Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

3.  Molecular basis for resistance to the anticancer drug cisplatin in Dictyostelium.

Authors:  Guochun Li; Hannah Alexander; Natalie Schneider; Stephen Alexander
Journal:  Microbiology (Reading)       Date:  2000-09       Impact factor: 2.777

4.  An oncogenic role of sphingosine kinase.

Authors:  P Xia; J R Gamble; L Wang; S M Pitson; P A Moretti; B W Wattenberg; R J D'Andrea; M A Vadas
Journal:  Curr Biol       Date:  2000-11-30       Impact factor: 10.834

Review 5.  Sphingosine 1-phosphate signalling in mammalian cells.

Authors:  S Pyne; N J Pyne
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

6.  The DPL1 gene is involved in mediating the response to nutrient deprivation in Saccharomyces cerevisiae.

Authors:  D Gottlieb; W Heideman; J D Saba
Journal:  Mol Cell Biol Res Commun       Date:  1999-04

7.  Promitogenic effects of ethanol, methanol, and ethanolamine in insulin-treated fibroblasts.

Authors:  K S Crilly; S Benyhe; Z Kiss
Journal:  Biochem Pharmacol       Date:  2000-11-01       Impact factor: 5.858

8.  Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22(1).

Authors:  P P Van Veldhoven; S Gijsbers; G P Mannaerts; J R Vermeesch; V Brys
Journal:  Biochim Biophys Acta       Date:  2000-09-27

9.  Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform.

Authors:  H Liu; M Sugiura; V E Nava; L C Edsall; K Kono; S Poulton; S Milstien; T Kohama; S Spiegel
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

10.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

Authors:  Y Liu; R Wada; T Yamashita; Y Mi; C X Deng; J P Hobson; H M Rosenfeldt; V E Nava; S S Chae; M J Lee; C H Liu; T Hla; S Spiegel; R L Proia
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

View more
  32 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

2.  Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity.

Authors:  Young-Jin Seo; Celeste Blake; Stephen Alexander; Bumsuk Hahm
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

Review 3.  Clinical application of ceramide in cancer treatment.

Authors:  Kazuki Moro; Masayuki Nagahashi; Emmanuel Gabriel; Kazuaki Takabe; Toshifumi Wakai
Journal:  Breast Cancer       Date:  2019-04-08       Impact factor: 4.239

Review 4.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

Review 5.  PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism.

Authors:  Florence Bourquin; Guido Capitani; Markus Gerhard Grütter
Journal:  Protein Sci       Date:  2011-09       Impact factor: 6.725

6.  Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate.

Authors:  Deanna L Siow; Charles D Anderson; Evgeny V Berdyshev; Anastasia Skobeleva; Stuart M Pitson; Binks W Wattenberg
Journal:  J Lipid Res       Date:  2010-04-12       Impact factor: 5.922

Review 7.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

8.  Scintillation Proximity Assay to Detect the Changes in Cellular Dihydrosphingosine 1-Phosphate Levels.

Authors:  Mamoru Ohtoyo; Masakazu Tamura; Nobuo Machinaga; Fumihito Muro; Ryuji Hashimoto
Journal:  Lipids       Date:  2016-09-02       Impact factor: 1.880

Review 9.  Sphingolipids in mitochondria.

Authors:  María José Hernández-Corbacho; Mohamed F Salama; Daniel Canals; Can E Senkal; Lina M Obeid
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-30       Impact factor: 4.698

10.  Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals.

Authors:  Nicholas C Zitomer; Trevor Mitchell; Kenneth A Voss; Genevieve S Bondy; Sarah T Pruett; Ethel C Garnier-Amblard; Lanny S Liebeskind; Hyejung Park; Elaine Wang; M Cameron Sullards; Alfred H Merrill; Ronald T Riley
Journal:  J Biol Chem       Date:  2008-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.